The goal of mRNA technology is to harness the power of the cell to potentially prevent infections and treat diseases.
Academic rigor, journalistic flair
Articles on Cancer immunotherapy
Displaying all articles
T cells recognize and kill cancer cells but quickly lose their effectiveness. This fast dysfunction may help explain why immunotherapy doesn’t lead to long-term remission for many patients.
From cancer immunotherapy and antibiotics to GMO crops and pandemic surveillance, gain of function is a cornerstone of basic research.
There is no one-size-fits-all approach to treating cancer. Understanding how cancer cells evolve could help researchers develop more effective drugs.
Preventive and therapeutic vaccines both train the immune system to fight disease, but they are used in different ways.
Immunotherapy has the potential to eliminate tumors, but works best for select patients. Engineering T cells to bypass cancer’s defenses could help expand treatment eligibility to more patients.
October is awash in seas of pink T-shirts, balloons and ribbons in honor of Breast Cancer Awareness Month. But this messaging fails to recognize people who are not cured of the disease.
One promising cancer treatment has been in the works for decades, but severe side effects have kept it out of the clinic. A reengineered version may offer a way to safely harness its potent effects.
The parasite which causes toxoplasmosis has shown promise in treating difficult tumours in mice.
Researchers are trying to boost the power of our immune system by genetically altering our white blood cells and transforming them into super-soldiers to fight cancer.
Most cancer research has been done in Europe, there’s minimal data on African populations.
Cancer immunotherapy is a revolutionary treatment for many but it can cause nasty side effects like inflammation of the colon that can derail treatment. Could the solution be a fecal transplant?
James Allison and Tasuku Honjo won the 2018 Nobel Prize in Physiology or Medicine for encouraging immune cells to attack cancer. See how their work has revolutionized cancer therapies and medicine.
Some argue the current system of subsidising drugs in Australia needs changing to accommodate new cancer therapies. But two recent drug listings show the current system is working perfectly well.
An independent expert provides his pick of the most notable drugs added to the PBS on May 1, 2017.
By tampering with the machinery which allows aggressive cancer cells to adapt, we can disrupt their ecosystem.
New immunotherapy drugs that enhance the body’s natural ability to fight cancer offer several key advantages over previous treatments.
If you can’t find the specific T cells you need to fight a cancer, make them.
’Tis the season for listicles rounding up the stories of the year. So with, the authority vested in me, here is a selection of six top, bottom and forgotten science stories of 2014. Bounciest landing The…
The trouble with treating cancer is that each type has its own quirks. The quirks of pancreatic cancer make it one of the most lethal. The survival period after diagnosis is only four to six months. The…
Top contributors
-
Dean, Faculty of Medical and Health Sciences, University of Auckland
-
MD-Ph.D. Candidate in Molecular Pathology and Immunology, Vanderbilt University
-
Assistant Professor of Medicine and Pathology, Vanderbilt University
-
Professor of Health Economics, Deputy Director of CHERE, University of Technology Sydney
-
Professor of Science Communication and Chemistry, University of Hull
-
Professor of Health Economics, University of Technology Sydney
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Graduate Student in Cancer Systems Biology, Rice University
-
Senior Research Fellow, University of Technology Sydney
-
Professor of Interdisciplinary Parasitology, University of Nottingham
-
Lecturer in Neuroscience, University of Central Lancashire
-
Postdoctoral research scientist, Columbia University
-
Professor of Experimental Cancer Research, University of Southampton
-
Postdoctoral Research Fellow in Materials Science and Engineering, Stanford University
-
Professor of Neurosurgery, University of Florida
